A. Lobo

A. Lobo, B. Feagan, V. Jairath, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Infliximab induction regimens in steroid‐refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis

N. Kennedy, J. Brooks, G. Moran, 2019, Alimentary pharmacology & therapeutics.

Crohn's disease: management in adults, children and young people - concise guidance .

A. Lobo, G. Tun, S. Cripps, 2018, Clinical medicine.

A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom

Steven Brown, David S Sanders, Simon S Cross, 2003, American Journal of Gastroenterology.

Systematic review of factors affecting transition readiness skills in patients with inflammatory bowel disease.

A. Lobo, Georgina L Jones, R. Tattersall, 2020, Journal of Crohn's & colitis.

A Systematic Review of Internet Decision-Making Resources for Patients Considering Surgery for Ulcerative Colitis

A. Lobo, Georgina L Jones, S. Brown, 2017, Inflammatory bowel diseases.

Stem cell transplantation for inflammatory bowel disease: practical and ethical issues

C. Hawkey, J. Snowden, C. Beglinger, 2000, Gut.

Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio‐economic status

D. Sanders, A. Lobo, T. Winstanley, 2001, Alimentary pharmacology & therapeutics.

Colorectal laterally spreading tumors: Clinical evaluation and endoscopic strategies updated

D. P. Hurlstone, A. Lobo, C. Korulla, 2002, Journal of gastroenterology and hepatology.

A 1 mm Depressed Type IIC Minute Colorectal Cancer: First Reported Case and Discussion of Clinical Relevance, with Special Reference to Endoscopic Diagnosis

S. Cross, D. P. Hurlstone, A. Lobo, 2003, Journal of gastroenterology and hepatology.

High‐magnification‐chromoscopic‐colonoscopy: a role for screening and treatment in attenuated familial adenomatous polyposis?

A. Lobo, D. P. Hurstone, M. A. Karegeh, 2002, Journal of gastroenterology and hepatology.

Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers

S. Cross, D. Sanders, A. Lobo, 2002, American Journal of Gastroenterology.

Sheffield Clinical Research Fellowship programme: a transferable model for UK gastroenterology

R. Sidhu, D. Sanders, M. McAlindon, 2017, Frontline Gastroenterology.

Prodromal Irritable Bowel Syndrome May Be Responsible for Delays in Diagnosis in Patients Presenting with Unrecognized Crohn’s Disease and Celiac Disease, but Not Ulcerative Colitis

D. Sanders, M. McAlindon, A. Lobo, 2011, Digestive Diseases and Sciences.

Failure of colonoscopic surveillance in ulcerative colitis.

A. Axon, A. Lobo, M. Dixon, 1993, Gut.

Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics.

B. Sharrack, A. Lobo, R. Grünewald, 2003, Brain : a journal of neurology.

Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases – a guide for the generalist

B. Sharrack, J. Snowden, A. Lobo, 2018, Clinical medicine.

A primary care cross-sectional study of undiagnosed adult coeliac disease

T. Stephenson, E. McCloskey, D. Sanders, 2003, European journal of gastroenterology & hepatology.

What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.

D. Sanders, M. McAlindon, D. P. Hurlstone, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

Philip Smith, C. Lees, N. Bhala, 2021, The Lancet Gastroenterology & Hepatology.

Allele 2 of the interleukin-1 receptor antagonist gene polymorphism is associated with reduced expression of interleukin-1 receptor antagonist in ulcerative colitis

N. Camp, A. Lobo, G. Duff, 1998 .

Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

C. Lees, N. Bhala, C. Lamb, 2020, Frontline Gastroenterology.

Review article: pathogenesis of Crohn's perianal fistula—understanding factors impacting on success and failure of treatment strategies

A. Hart, S. Sebastian, A. Lobo, 2018, Alimentary pharmacology & therapeutics.

The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe

A. Lobo, B. Hayee, L. Peyrin-Biroulet, 2020, BMC Gastroenterology.

Diagnosing and managing inflammatory bowel disease.

A. Lobo, A. Assadsangabi, 2013, The Practitioner.

Systematic Review: Predicting the Development of Psychological Morbidity in Inflammatory Bowel Disease

A. Lobo, G. Rowse, A. Hoogkamer, 2020 .

Research outcomes in British gastroenterology: an audit of the subsequent full publication of abstracts presented at the British Society of Gastroenterology

D. Sanders, D. P. Hurlstone, A. Lobo, 2001 .

Combined modality treatment for complex fistulating perianal Crohn’s disease

A. Lobo, A. Shorthouse, R. Antakia, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study

R. Emsley, M. Parkes, J. Satsangi, 2019, BMC Gastroenterology.

The Simplified Acute Physiology Score (SAPSII): Is there a role in assessing patients with medically refractory upper gastrointestinal bleeding?

D. Sanders, A. Lobo, M. Carter, 2001 .

Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis?

R. Sidhu, D. Sanders, M. McAlindon, 2010, Inflammatory bowel diseases.

Genes, bacteria and inflammatory bowel disease

A. Lobo, M. Carter, M. Carter, 2001 .

Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire

D. Sanders, D. P. Hurlstone, A. Lobo, 2002, Postgraduate medical journal.

Patients with perianal Crohn's fistulas experience delays in accessing anti‐TNF therapy due to slow recognition, diagnosis and integration of specialist services: lessons learned from three referral centres

M. Parkes, A. Hart, A. Lobo, 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Ulcerative colitis: management in adults, children and young people - concise guidance .

A. Lobo, A. Harris, G. Tun, 2017, Clinical medicine.

Diagnosis and treatment of inflammatory bowel disease.

A. Lobo, Sarah Taylor, S. Taylor, 2016, The Practitioner.

Infliximab use in Crohn's disease: impact on health care resources in the UK

H. Drummond, J. Satsangi, A. Forbes, 2005, European journal of gastroenterology & hepatology.

The role of azathioprine in the management of ulcerative colitis

A. Axon, A. Lobo, D. Burke, 1990, Diseases of the colon and rectum.

Polymerase chain reaction for detection of mucosal cytomegalovirus infection in patients with acute ulcerative colitis

A. Lobo, M. Raza, M. Hale, 2018, Annals of gastroenterology.

Prospective evaluation of high-frequency mini-probe ultrasound colonoscopic imaging in ulcerative colitis: a valid tool for predicting clinical severity

S. Cross, D. Sanders, M. McAlindon, 2005, European journal of gastroenterology & hepatology.

Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

C. J. Taylor, S. Cross, A. Hollander, 1999, Gastroenterology.

High prevalence of antibodies to infliximab and their relation to clinical outcomes in inflammatory bowel disease patients

A. Lobo, R. Sargur, M. Hale, 2019, GastroHep.

Preservation of gastric antral mucus is associated with failure of eradication of Helicobacter pylori by bismuth, metronidazole and tetracycline

C. Mcnulty, A. Lobo, S. Wilkinson, 1994, Alimentary pharmacology & therapeutics.

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

A. Axon, A. Lobo, J. Crabtree, 1990, Gut.

Can faecal lactoferrin be used as a discriminator for referral for colonoscopy?

R. Sidhu, D. Sanders, M. McAlindon, 2010, Internal medicine journal.

Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.

A. Lobo, R. Leicester, C. Holdsworth, 1998, Gastroenterology.

High-magnification chromoscopic ileoscopy in familial adenomatous polyposis: detection in vivo of colonic metaplasia and microadenoma formation.

S. Cross, D. P. Hurlstone, A. Lobo, 2004, Endoscopy.

Oral tobramycin in ulcerative colitis: effect on maintenance of remission

A. Lobo, D. Burke, G. Sobala, 1993, Alimentary pharmacology & therapeutics.

Effect of oral cyclosporin on renal function in Crohn's disease

A. Axon, A. Lobo, J. Pentith, 1993, Digestive Diseases and Sciences.

Acute upper gastrointestinal bleeding.

A. Lobo, M. Kurien, 2015, Clinical medicine.

A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis.

Steven R. Brown, A. Lobo, Georgina L Jones, 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care

D. Sanders, M. McAlindon, D. P. Hurlstone, 2001, The Lancet.

Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease

D. Sanders, A. Lobo, L. Lennard, 2004, Gut.

Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?

M. McAlindon, D. P. Hurlstone, A. Lobo, 2006, Alimentary pharmacology & therapeutics.

Value of ultrasound and liver function tests in determining the need for endoscopic retrograde cholangiopancreatography in unexplained abdominal pain.

A. Axon, A. Lobo, J. Thornton, 1992, Gut.

Haemopoietic stem cell transplantation—an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology

B. Sharrack, J. Snowden, A. Wilson, 2007, Hematology.

Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

Alastair Forbes, Carlo Berzuini, Lon Cardon, 2008, Nature Genetics.

Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.

C. Carroll, P. Tappenden, A. Lobo, 2016, Health technology assessment.

Long-term treatment of Crohn's disease with cyclosporine: the effect of a very low dose on maintenance of remission.

A. Axon, A. Lobo, J. Rothwell, 1991, Journal of clinical gastroenterology.

Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.

P. Deloukas, D. Strachan, S. Hunt, 2009, Gastroenterology.

Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.

S. Cross, D. Sanders, M. McAlindon, 2004, Gastroenterology.

Predicting the development of psychological morbidity in inflammatory bowel disease: a systematic review

A. Lobo, G. Rowse, A. Hoogkamer, 2020, Frontline Gastroenterology.

Keratins in colorectal epithelial function and disease

B. Corfe, A. Lobo, C. Evans, 2012, International journal of experimental pathology.

A prospective evaluation of high-magnification chromoscopic colonoscopy in predicting completeness of EMR.

S. Cross, D. Sanders, D. P. Hurlstone, 2004, Gastrointestinal endoscopy.

Histological assessment of the Sydney classification of endoscopic gastritis.

N. Shepherd, S. Khakoo, A. Lobo, 1994, Gut.

The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis.

A. Cox, A. Shorthouse, A. Lobo, 2001, Gastroenterology.

Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians

N. Camp, A. Lobo, G. Duff, 2001, Gut.

The assessment of online health videos for surgery in Crohn's disease

A. Lobo, M. Lee, S. Brown, 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

M. Parkes, C. Lees, J. Satsangi, 2014, Alimentary Pharmacology and Therapeutics.

How are we managing fistulating perianal Crohn’s disease? Results of a national survey of consultant gastroenterologists

Steven R. Brown, A. Hart, A. Lobo, 2017, Frontline Gastroenterology.

Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease

D. Sanders, M. McAlindon, P. Shah, 2011, European journal of gastroenterology & hepatology.

Systematic review: psychological morbidity in young people with inflammatory bowel disease – risk factors and impacts

B. Corfe, A. Lobo, E. Peach, 2016, Alimentary pharmacology & therapeutics.

High magnification chromoscopic colonoscopy as a screening tool in acromegaly

S. Cross, D. Sanders, D. P. Hurlstone, 2003, Gut.

Are mesalazine granules superior to Eudragit‐L‐coated mesalazine tablets for induction of remission in distal ulcerative colitis?

A. Lobo, A. Brooks, 2012, Alimentary pharmacology & therapeutics.

Commentary: impact of MMX mesalazine on health‐related quality of life in ulcerative colitis

A. Lobo, A. Marsh, 2012, Alimentary pharmacology & therapeutics.

Audit of the histopathological diagnosis of non-neoplastic colorectal biopsies: achievable standards for the diagnosis of inflammatory bowel disease.

S S Cross, A K Dube, S. Cross, 1998, Journal of clinical pathology.

The Informational Needs and Preferences of Patients Considering Surgery for Ulcerative Colitis: Results of a Qualitative Study.

A. Lobo, Georgina L Jones, S. Brown, 2017, Inflammatory bowel diseases.

Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?

S. Cross, D. Sanders, M. McAlindon, 2006, Gut.

Effectiveness of an upper-gastrointestinal haemorrhage unit: a prospective analysis of 900 consecutive cases using the Rockall score as a method of risk standardisation

D. Sanders, A. Lobo, E. Mcfarlane, 2004, European journal of gastroenterology & hepatology.

Simplified acute physiology score II: A valid role in the assessment of patients with medically refractory upper gastrointestinal bleeding?

D. P. Hurlstone, A. Lobo, D. Sanders, 2003, Journal of gastroenterology and hepatology.

Deficiencies in services for acute upper gastrointestinal bleeding

I. Forgacs, A. Lobo, S. Greenfield, 2015, BMJ : British Medical Journal.

Changing trends in the UK management of upper GI bleeding: is there evidence of reduced UK training experience?

A. Lobo, C. Romaya, R. Ahmed, 2015, Frontline Gastroenterology.

Upper gastrointestinal bleeding in the UK: does a dedicated bleed unit improve outcomes?

R. Sidhu, D. Sanders, A. Lobo, 2011, Gut.

CROHN'S DISEASE IN MARRIED COUPLES

A. Lobo, G. Sobala, P. Foster, 1988, The Lancet.

A perianal ulcer

A. Lobo, M. Leach, M. Mckendrick, 1999, The Lancet.

Autologous stem cell transplantation in severe treatment-resistant Crohn's disease: long-term follow-up of UK patients treated on compassionate basis.

J. Snowden, A. Lobo, G. Jackson, 2014, QJM : monthly journal of the Association of Physicians.

Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn’s disease

A. Lobo, G. Tun, 2015, Expert opinion on drug metabolism & toxicology.

Outcome of elective withdrawal of anti-tumour necrosis factor-&agr; therapy in patients with Crohn's disease in established remission*

S. Cross, M. McAlindon, S. Sebastian, 2014, Journal of Crohn's & colitis.

Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

M. Stevenson, A. Lobo, A. Scope, 2016, PharmacoEconomics.

Plasma viscosity in inflammatory bowel disease.

A. Axon, A. Lobo, A. Lobo, 1992, Journal of clinical pathology.

Lack of effect of intravenous azathioprine on time to respond for steroid treated Crohn's disease

A. Lobo, M. Carter, 2001, Gut.

A Patient Knowledge Questionnaire in Inflammatory Bowel Disease

A. Axon, A. Lobo, A T Axon, 1993, Journal of clinical gastroenterology.

Quantitative Magnetic Resonance Imaging in Perianal Crohn’s Disease at 1.5 and 3.0 T: A Feasibility Study

J. Mclaughlin, C. Tench, A. Hart, 2021, Diagnostics.

NICE clinical guideline (CG152): the management of Crohn's disease in adults, children and young people

A. Ford, A. Lobo, J. Mayberry, 2013, Alimentary pharmacology & therapeutics.

Endoscopic morphological anticipation of submucosal invasion in flat and depressed colorectal lesions: clinical implications and subtype analysis of the kudo type V pit pattern using high‐magnification‐chromoscopic colonoscopy

S. Cross, D. Sanders, D. P. Hurlstone, 2004, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Assessing resection margins using high-magnification chromoscopy: a useful tool after colonic endoscopic mucosal resection

D. P. Hurlstone, A. Lobo, 2002, American Journal of Gastroenterology.

Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection

S. Cross, D. Sanders, D. P. Hurlstone, 2004, Gut.

A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom.

S. Cross, D. Sanders, D. P. Hurlstone, 2003 .

Early detection of colorectal cancer using high‐magnification chromoscopic colonoscopy

D. P. Hurlstone, T. Fujii, A. Lobo, 2002, The British journal of surgery.

High-magnification chromoscopic pouchoscopy: a novel in vivo technique for surveillance of the anal transition zone and columnar cuff following ileal pouch-anal anastomosis

S. Cross, D. Sanders, D. P. Hurlstone, 2004, Techniques in Coloproctology.

Efficacy of high magnification chromoscopic colonoscopy for the diagnosis of neoplasia in flat and depressed lesions of the colorectum: a prospective analysis

S S Cross, S. Cross, D. Sanders, 2004, Gut.

Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.

S. Cross, D. Sanders, M. McAlindon, 2005, Endoscopy.

An evaluation of colorectal endoscopic mucosal resection using high-magnification chromoscopic colonoscopy: a prospective study of 1000 colonoscopies.

S. Cross, D. Sanders, D. P. Hurlstone, 2004, Endoscopy.

Reducing the risk of interval colorectal neoplasia: high magnification chromoscopic colonoscopy may offer a key resource?

S. Cross, D. Sanders, D. P. Hurlstone, 2006, Gastroenterology.

P245 A systematic review of outcomes reported in studies on fistulising perianal Crohn's disease.

O. Faiz, A. Hart, S. Sebastian, 2017, Journal of Crohn's & Colitis.

Drug-induced Liver Injury Associated with Antinuclear Antibodies

D. Sanders, A. Lobo, M. Carter, 2002 .

Carriage of adhesive Escherichia coli after restorative proctocolectomy and pouch anal anastomosis: relation with functional outcome and inflammation.

P. Quirke, A. Lobo, D. Johnston, 1993, Gut.

Economic analysis of the adoption of capsule endoscopy within the British NHS

M. McAlindon, A. Lobo, R. Saunders, 2020, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Pillcam colon capsule is an effective tool in management of patients with suspected or known inflammatory bowel disease: preliminary results from a UK tertiary care centre

R. Sidhu, M. McAlindon, A. Lobo, 2011, Gut.

Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care

S. Cross, R. Sidhu, A. Lobo, 2017, Journal of Clinical Pathology.

Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer

S. Cross, B. Corfe, A. Lobo, 2015, BMJ open gastroenterology.

An integrated workflow for extraction and solubilization of intermediate filaments from colorectal biopsies for proteomic analysis

B. Corfe, P. Wright, A. Lobo, 2012, Electrophoresis.

Gastric antral vascular ectasia as the only presenting feature of limited cutaneous systemic sclerosis.

M. Snaith, D. Sanders, A. Lobo, 2002, Journal of clinical gastroenterology.

Monitoring established Crohn’s disease with pan-intestinal video capsule endoscopy in Europe: clinician consultation using the nominal group technique

C. Carretero, M. Ferrante, A. Lobo, 2021, Current medical research and opinion.